Prostate cancer articles within Scientific Reports

Featured

• Article
  23 May 2024 | Open Access

  Synthesis and new DNA targeting activity of 6- and 7-tert-butylfascaplysins

  • Sergey A. Dyshlovoy
  • , Wael Y. Mansour
  •  & Gunhild von Amsberg

• Article
  22 May 2024 | Open Access

  Comprehensive data mining reveals RTK/RAS signaling pathway as a promoter of prostate cancer lineage plasticity through transcription factors and CNV

  • Guanyun Wei
  • , Xu Zhang
  •  & Zao Dai

• Article
  17 May 2024 | Open Access

  Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLT

  • Florian Rosar
  • , Caroline Burgard
  •  & Samer Ezziddin

• Article
  15 May 2024 | Open Access

  Analysis of androgen receptor expression and activity in the mouse brain

  • D. Alwyn Dart
  • , Charlotte L. Bevan
  •  & Wen Guo Jiang

• Article
  13 May 2024 | Open Access

  A bicentric retrospective study of the correlation of EAU BCR risk groups with ¹⁸F-PSMA-1007 PET/CT detection in prostate cancer biochemical recurrence

  • Nathan Poterszman
  • , Charles Merlin
  •  & François Somme

• Article
  11 May 2024 | Open Access

  Hematological and renal toxicity in mice after three cycles of high activity [¹⁷⁷Lu]Lu-PSMA-617 with or without human α₁-microglobulin

  • Amanda Kristiansson
  • , Oskar Vilhelmsson Timmermand
  •  & Anders Örbom

• Article
  26 April 2024 | Open Access

  Increasing the efficiency of cone-beam CT based delta-radiomics using automated contours to predict radiotherapy-related toxicities in prostate cancer

  • Rodrigo Delgadillo
  • , Anthony M. Deana
  •  & Nesrin Dogan

• Article
  21 April 2024 | Open Access

  Salvage prostate intensity modulated radiation therapy after cryotherapy failure

  • Tanguy Perennec
  • , Maximilien Rogé
  •  & Stéphane Supiot

• Article
  17 April 2024 | Open Access

  Tumor promoting effect of spheroids in an orthotopic prostate cancer mouse model

  • Julius Lars Daniel Bastian
  • , Philip Zeuschner
  •  & Johannes Linxweiler

• Article
  08 April 2024 | Open Access

  Androgen deprivation alone versus combined with pelvic radiation for adverse events and quality of life in clinically node-positive prostate cancer

  • Tae Hoon Lee
  • , Hongryull Pyo
  •  & Won Park

• Article
  25 March 2024 | Open Access

  Clinically-observed FOXA1 mutations upregulate SEMA3C through transcriptional derepression in prostate cancer

  • Kevin J. Tam
  • , Liangliang Liu
  •  & Christopher J. Ong

• Article
  19 March 2024 | Open Access

  PI-RADS v2.1 and PSAD for the prediction of clinically significant prostate cancer among patients with PSA levels of 4–10 ng/ml

  • Jing Wen
  • , Wei Liu
  •  & Wei Hu

• Article
  11 March 2024 | Open Access

  Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomy

  • Masashi Kubota
  • , Mutsushi Kawakita
  •  & Takayuki Goto

• Article
  07 March 2024 | Open Access

  The learning curve for robotic-assisted transperineal MRI/US fusion-guided prostate biopsy

  • Viktor Alargkof
  • , Christian Engesser
  •  & Christian Wetterauer

• Article
  02 February 2024 | Open Access

  A novel exosome based therapeutic intervention against neuroendocrine prostate cancer

  • Sharanjot Saini
  • , Amritha Sreekumar
  •  & Matthew N. Simmons

• Article
  31 January 2024 | Open Access

  A digital image colorimetry system based on smart devices for immediate and simultaneous determination of enzyme-linked immunosorbent assays

  • Shaghayegh Mirhosseini
  • , Aryanaz Faghih Nasiri
  •  & Mohammadreza Kolahdouz

• Article
  18 January 2024 | Open Access

  Comprehensive plasma steroidomics reveals subtle alterations of systemic steroid profile in patients at different stages of prostate cancer disease

  • Sergey Girel
  • , Pavel A. Markin
  •  & Svetlana A. Appolonova

• Article
  02 January 2024 | Open Access

  Impact of radiation doses on clinical relapse of biochemically recurrent prostate cancer after prostatectomy

  • Seiya Takano
  • , Natsuo Tomita
  •  & Akio Hiwatashi

• Article
  17 December 2023 | Open Access

  Association between copy number alterations estimated using low-pass whole genome sequencing of formalin-fixed paraffin-embedded prostate tumor tissue and cancer-specific clinical parameters

  • Paul Vinu Salachan
  • , Benedicte Parm Ulhøi
  •  & Karina Dalsgaard Sørensen

• Article
  13 December 2023 | Open Access

  Long-term findings of rectal endoscopy and rectal bleeding after moderately hypofractionated, intensity-modulated radiotherapy for prostate cancer

  • Bong Kyung Bae
  • , Ji Eun Kim
  •  & Won Park

• Article
  09 December 2023 | Open Access

  Transfer learning with CNNs for efficient prostate cancer and BPH detection in transrectal ultrasound images

  • Te-Li Huang
  • , Nan-Han Lu
  •  & Tai-Been Chen

• Article
  16 November 2023 | Open Access

  Risk of secondary malignancy following radiation therapy for prostate cancer

  • Tenaw Tiruye
  • , Rowan David
  •  & Kerri Beckmann

• Article
  13 November 2023 | Open Access

  Addressing image misalignments in multi-parametric prostate MRI for enhanced computer-aided diagnosis of prostate cancer

  • Balint Kovacs
  • , Nils Netzer
  •  & Klaus H. Maier-Hein

• Article
  08 November 2023 | Open Access

  Prostate cancer treatment in Portugal: a nationwide analysis

  • Francisco Botelho
  • , Rui Lopes
  •  & Nuno Lunet

• Article
  06 November 2023 | Open Access

  Impact of germline DNA repair gene variants on prognosis and treatment of men with advanced prostate cancer

  • Emma B. Hansen
  • , Questa Karlsson
  •  & Karina D. Sørensen

• Article
  27 October 2023 | Open Access

  Development of machine learning prognostic models for overall survival of prostate cancer patients with lymph node-positive

  • Zi-He Peng
  • , Juan-Hua Tian
  •  & Zhao-Lun Li

• Article
  25 October 2023 | Open Access

  MED19 encodes two unique protein isoforms that confer prostate cancer growth under low androgen through distinct gene expression programs

  • Rachel Ruoff
  • , Hannah Weber
  •  & Michael J. Garabedian

• Article
  20 October 2023 | Open Access

  Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer

  • Astrid Børretzen
  • , Lars A. R. Reisæter
  •  & Ole J. Halvorsen

• Article
  18 October 2023 | Open Access

  Untargeted lipidomics reveal association of elevated plasma C18 ceramide levels with reduced survival in metastatic castration-resistant prostate cancer patients

  • Carlo Cattrini
  • , Marcello Manfredi
  •  & Alessandra Gennari

• Article
  10 October 2023 | Open Access

  Natural killer cell activity in metastatic castration resistant prostate cancer patients treated with enzalutamide

  • A. H. Zedan
  • , L. Nederby
  •  & T. F. Hansen

• Article
  09 October 2023 | Open Access

  The role of GCNT1 mediated O-glycosylation in aggressive prostate cancer

  • Kirsty Hodgson
  • , Margarita Orozco-Moreno
  •  & Jennifer Munkley

• Article
  03 October 2023 | Open Access

  Human papillomavirus and prostate cancer: systematic review and meta-analysis

  • Irina A. Tsydenova
  • , Marina K. Ibragimova
  •  & Nikolai V. Litviakov

• Article
  03 October 2023 | Open Access

  Functional consequences of A-to-I editing of miR-379 in prostate cancer cells

  • Gjendine Voss
  • , James R. Cassidy
  •  & Yvonne Ceder

• Article
  15 September 2023 | Open Access

  Longitudinal change in castration-resistant prostate cancer biomarker AST/ALT ratio reflects tumor progression

  • Yozo Mitsui
  • , Fumito Yamabe
  •  & Koichi Nakajima

• Article
  18 August 2023 | Open Access

  Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression

  • Joanna Lazniewska
  • , Ka Lok Li
  •  & Douglas A. Brooks

• Article
  27 July 2023 | Open Access

  Impact of delivery time factor on treatment time and plan quality in tomotherapy

  • Takayuki Yagihashi
  • , Tatsuya Inoue
  •  & Hironori Nagata

• Article
  18 July 2023 | Open Access

  MR imaging features to predict the type of bone metastasis in prostate cancer

  • Hiroaki Koyama
  • , Ryo Kurokawa
  •  & Osamu Abe

• Article
  21 June 2023 | Open Access

  Tumor localization by Prostate Imaging and Reporting and Data System (PI-RADS) version 2.1 predicts prognosis of prostate cancer after radical prostatectomy

  • Ayumi Fujimoto
  • , Shinichi Sakamoto
  •  & Tomohiko Ichikawa

• Article
  19 June 2023 | Open Access

  Analysis of the surgical approach in prostate cancer staging: results from the surveillance, epidemiology and end results program

  • Felipe Andrés Cordero da Luz
  • , Camila Piqui Nascimento
  •  & Marcelo José Barbosa Silva

• Article
  03 June 2023 | Open Access

  Investigation of enzalutamide, docetaxel, and cabazitaxel resistance in the castration resistant prostate cancer cell line C4 using genome-wide CRISPR/Cas9 screening

  • Jakob Haldrup
  • , Simone Weiss
  •  & Karina Dalsgaard Sørensen

• Article
  29 May 2023 | Open Access

  Bone scan index (BSI) scoring by using bone scintigraphy and circulating tumor cells (CTCs): predictive factors for enzalutamide effectiveness in patients with castration-resistant prostate cancer and bone metastases

  • Hisashi Hirano
  • , Masayoshi Nagata
  •  & Shigeo Horie

• Article
  22 May 2023 | Open Access

  Diagnostic value of two-time point [⁶⁸Ga]Ga-PSMA-11 PET/CT in the primary staging of untreated prostate cancer

  • Friedrich Weitzer
  • , Birgit Pernthaler
  •  & Reingard Maria Aigner

• Article
  10 May 2023 | Open Access

  Detection of high-risk Human Papillomavirus in prostate cancer from a UK based population

  • M. Yahya Ahmed
  • , Nadia Aziz Salman
  •  & G. Hossein Ashrafi

• Article
  24 April 2023 | Open Access

  Novel device for dividing core needle biopsy specimens to provide paired mirror image-like tissues for genetic and pathological tests

  • Yuichi Nakamura
  • , Keisuke Tsuji
  •  & Osamu Ukimura

• Article
  24 March 2023 | Open Access

  Predicting prostate cancer in men with PSA levels of 4–10 ng/mL: MRI-based radiomics can help junior radiologists improve the diagnostic performance

  • Jian-Guo Zhong
  • , Lin Shi
  •  & Yang Zhang

• Article
  08 March 2023 | Open Access

  R-LESS-RP versus C-LESS-RP: a single-institution retrospective comparative study

  • Yong Wei
  • , Qianying Ji
  •  & Qingyi Zhu

• Article
  27 February 2023 | Open Access

  Intraoperative mean arterial pressure and acute kidney injury after robot-assisted laparoscopic prostatectomy: a retrospective study

  • Tae Lim Kim
  • , Namo Kim
  •  & So Yeon Kim

• Article
  27 December 2022 | Open Access

  Prostate cancer malignancy detection and localization from mpMRI using auto-deep learning as one step closer to clinical utilization

  • Weiwei Zong
  • , Eric Carver
  •  & Xiangyun Zong

• Article
  19 December 2022 | Open Access

  Prebiopsy bpMRI and hematological parameter-based risk scoring model for predicting outcomes in biopsy-naive men with PSA 4–20 ng/mL

  • Yuxin Zheng
  • , Wang Li
  •  & Peng Ge

• Article
  07 December 2022 | Open Access

  Role of the elastography strain ratio using transrectal ultrasonography in the diagnosis of prostate cancer and clinically significant prostate cancer

  • Jeong Woo Yoo
  • , Kyo Chul Koo
  •  & Kwang Suk Lee